Wenjie Wang
State Key Laboratory Of Bioactive Substances And Functions Of Natural Medicines, Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, 100050, China
Beijing, 100050, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
A rapid and reliable targeted LC-MS/MS method for quantitative analysis of the Tryptophan-NAD metabolic network disturbances in tissues and blood of sleep deprivation mice.
Journal: Analytica chimica acta
Published: April 20, 2024
Assoication between self-reported sleep duration, physcial activity and the risk of all cause and cardiovascular diseases mortality from the NHANES database.
Journal: BMC cardiovascular disorders
Published: May 09, 2023
Evolution and mammalian adaptation of H3 and H10 subtype avian influenza viruses in wild birds in Yancheng Wetland of China.
Journal: Veterinary microbiology
Published: October 26, 2022
Effects of L-theanine on intestinal morphology, barrier function, and MAPK signaling pathways in diquat-challenged piglets.
Journal: Animal biotechnology
Published: December 14, 2021
HLJ2 Effectively Ameliorates Colitis-Associated Cancer via Inhibition of NF-κB and Epithelial-Mesenchymal Transition.
Journal: Drug design, development and therapy
Published: May 28, 2020
Dietary iron and vitamins in association with mortality.
Journal: Clinical nutrition (Edinburgh, Scotland)
Published: November 15, 2019
Isotalatizidine, a C19-diterpenoid alkaloid, attenuates chronic neuropathic pain through stimulating ERK/CREB signaling pathway-mediated microglial dynorphin A expression.
Journal: Journal of neuroinflammation
Published: September 30, 2019
Butyric Acid Increases the Therapeutic Effect of EHLJ7 on Ulcerative Colitis by Inhibiting JAK2/STAT3/SOCS1 Signaling Pathway.
Journal: Frontiers in pharmacology
Published: July 11, 2019
Discovery and evaluation of ZT55, a novel highly-selective tyrosine kinase inhibitor of JAK2V617F against myeloproliferative neoplasms.
Journal: Journal of experimental & clinical cancer research : CR
Published: November 22, 2018
Development of an XBP1 agonist, HLJ2, as a potential therapeutic agent for ulcerative colitis.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: May 18, 2017
Colitis Is Effectively Ameliorated by (±)-8-Acetonyl-dihydrocoptisine via the XBP1-NF-κB Pathway.
Journal: Frontiers in pharmacology
Published: May 10, 2017
Last Updated: 09/26/2026